Demographic and Clinical Characteristics of 866 914 children 0–17 Years Old With SARS-CoV-2 Viral Testing
| . | All Tested Patients . | SARS-CoV-2 Viral Testing Result . | . | |
|---|---|---|---|---|
| Characteristic . | Negative . | Positive . | P . | |
| Age, y, mean (SD) | 6.9 (5.3) | 6.8 (5.3) | 8.0 (5.5) | <.001 |
| Age categories, y, n (%) | <.001 | |||
| <1 | 99 879 (11.5) | 91 539 (11.7) | 8340 (10.1) | |
| 1–4 | 257 414 (29.7) | 238 433 (30.4) | 18 981 (22.9) | |
| 5–11 | 298 010 (34.4) | 268 298 (34.2) | 29 712 (35.9) | |
| 12–17 | 211 611 (24.4) | 185 846 (23.7) | 25 765 (31.1) | |
| Sex, n (%) | <.001 | |||
| Male | 458 463 (52.9) | 415 545 (53.0) | 42 918 (51.8) | |
| Female | 408 291 (47.1) | 368 419 (47.0) | 39 872 (48.2) | |
| Race or ethnicity, n (%) | <.001 | |||
| Hispanic | 138 251 (15.9) | 123 102 (15.7) | 15 149 (18.3) | |
| Non-Hispanic Black/African-American | 130 939 (15.1) | 114 323 (14.6) | 16 616 (20.1) | |
| Asian American/Pacific Islander | 38 512 (4.4) | 36 073 (4.6) | 2439 (2.9) | |
| Non-Hispanic White | 435 706 (50.3) | 398 263 (50.8) | 37 443 (45.2) | |
| Other/missing | 123 506 (14.2 | 112 355 (14.3) | 11 151 (13.5) | |
| Health system, n (%) | <.001 | |||
| A | 130 515 (15.1) | 117 968 (15.0) | 12 547 (15.2) | |
| B | 50 425 (5.8) | 48 650 (6.2) | 1775 (2.1) | |
| C | 181 911 (21.0) | 162 644 (20.7) | 19 267 (23.3) | |
| D | 47 021 (5.4) | 41 627 (5.3) | 5394 (6.5) | |
| E | 153 036 (17.7) | 134 011 (17.1) | 19 025 (23.0) | |
| F | 144 821 (16.7) | 130 544 (16.6) | 14 277 (17.2) | |
| G | 43 553 (5.0) | 40 904 (5.2) | 2649 (3.2) | |
| H | 51 687 (6.0) | 47 341 (6.0) | 4346 (5.2) | |
| I | 63 945 (7.4) | 60 427 (7.7) | 3518 (4.2) | |
| Chronic conditions, n (%) | <.001 | |||
| None | 661 797 (76.3) | 598 177 (76.3) | 63 620 (76.8) | |
| Noncomplex chronic | 108 636 (12.5) | 97 612 (12.4) | 11 024 (13.3) | |
| Complex chronic | 96 481 (11.1) | 88 327 (11.3) | 8154 (9.8) | |
| Health conditions, n (%) | ||||
| Asthma, no previous hospitalization | 56 292 (6.5) | 49 694 (6.3) | 6598 (8.0) | <.001 |
| Asthma, previous hospitalization | 25 681 (3.0) | 23 233 (3.0) | 2448 (3.0) | .927 |
| Cancer, not actively treated | 5213 (0.6) | 4827 (0.6) | 386 (0.5) | <.001 |
| Cancer, actively treated | 1577 (0.2) | 1289 (0.2) | 288 (0.3) | <.001 |
| Cardiac disorder | 43 505 (5.0) | 40 160 (5.1) | 3345 (4.0) | <.001 |
| Diabetes | 5655 (0.7) | 5161 (0.7) | 494 (0.6) | .038 |
| Immunologic disorder | 9905 (1.1) | 8908 (1.1) | 997 (1.2) | .083 |
| Mental health disorder | 86 757 (10.0) | 78 341 (10.0) | 8416 (10.2) | .115 |
| Obesity | 176 296 (20.3) | 158 666 (20.2) | 17 630 (21.3) | <.001 |
| Prematurity | 22 488 (2.6) | 20 734 (2.6) | 1754 (2.1) | <.001 |
| Renal disorder | 17 890 (2.1) | 16 448 (2.1) | 1442 (1.7) | <.001 |
| Sickle cell disease | 1178 (0.1) | 1000 (0.1) | 178 (0.2) | <.001 |
| Trisomy 21 | 280 (<0.1) | 257 (<0.1) | 23 (<0.1) | .510 |
| . | All Tested Patients . | SARS-CoV-2 Viral Testing Result . | . | |
|---|---|---|---|---|
| Characteristic . | Negative . | Positive . | P . | |
| Age, y, mean (SD) | 6.9 (5.3) | 6.8 (5.3) | 8.0 (5.5) | <.001 |
| Age categories, y, n (%) | <.001 | |||
| <1 | 99 879 (11.5) | 91 539 (11.7) | 8340 (10.1) | |
| 1–4 | 257 414 (29.7) | 238 433 (30.4) | 18 981 (22.9) | |
| 5–11 | 298 010 (34.4) | 268 298 (34.2) | 29 712 (35.9) | |
| 12–17 | 211 611 (24.4) | 185 846 (23.7) | 25 765 (31.1) | |
| Sex, n (%) | <.001 | |||
| Male | 458 463 (52.9) | 415 545 (53.0) | 42 918 (51.8) | |
| Female | 408 291 (47.1) | 368 419 (47.0) | 39 872 (48.2) | |
| Race or ethnicity, n (%) | <.001 | |||
| Hispanic | 138 251 (15.9) | 123 102 (15.7) | 15 149 (18.3) | |
| Non-Hispanic Black/African-American | 130 939 (15.1) | 114 323 (14.6) | 16 616 (20.1) | |
| Asian American/Pacific Islander | 38 512 (4.4) | 36 073 (4.6) | 2439 (2.9) | |
| Non-Hispanic White | 435 706 (50.3) | 398 263 (50.8) | 37 443 (45.2) | |
| Other/missing | 123 506 (14.2 | 112 355 (14.3) | 11 151 (13.5) | |
| Health system, n (%) | <.001 | |||
| A | 130 515 (15.1) | 117 968 (15.0) | 12 547 (15.2) | |
| B | 50 425 (5.8) | 48 650 (6.2) | 1775 (2.1) | |
| C | 181 911 (21.0) | 162 644 (20.7) | 19 267 (23.3) | |
| D | 47 021 (5.4) | 41 627 (5.3) | 5394 (6.5) | |
| E | 153 036 (17.7) | 134 011 (17.1) | 19 025 (23.0) | |
| F | 144 821 (16.7) | 130 544 (16.6) | 14 277 (17.2) | |
| G | 43 553 (5.0) | 40 904 (5.2) | 2649 (3.2) | |
| H | 51 687 (6.0) | 47 341 (6.0) | 4346 (5.2) | |
| I | 63 945 (7.4) | 60 427 (7.7) | 3518 (4.2) | |
| Chronic conditions, n (%) | <.001 | |||
| None | 661 797 (76.3) | 598 177 (76.3) | 63 620 (76.8) | |
| Noncomplex chronic | 108 636 (12.5) | 97 612 (12.4) | 11 024 (13.3) | |
| Complex chronic | 96 481 (11.1) | 88 327 (11.3) | 8154 (9.8) | |
| Health conditions, n (%) | ||||
| Asthma, no previous hospitalization | 56 292 (6.5) | 49 694 (6.3) | 6598 (8.0) | <.001 |
| Asthma, previous hospitalization | 25 681 (3.0) | 23 233 (3.0) | 2448 (3.0) | .927 |
| Cancer, not actively treated | 5213 (0.6) | 4827 (0.6) | 386 (0.5) | <.001 |
| Cancer, actively treated | 1577 (0.2) | 1289 (0.2) | 288 (0.3) | <.001 |
| Cardiac disorder | 43 505 (5.0) | 40 160 (5.1) | 3345 (4.0) | <.001 |
| Diabetes | 5655 (0.7) | 5161 (0.7) | 494 (0.6) | .038 |
| Immunologic disorder | 9905 (1.1) | 8908 (1.1) | 997 (1.2) | .083 |
| Mental health disorder | 86 757 (10.0) | 78 341 (10.0) | 8416 (10.2) | .115 |
| Obesity | 176 296 (20.3) | 158 666 (20.2) | 17 630 (21.3) | <.001 |
| Prematurity | 22 488 (2.6) | 20 734 (2.6) | 1754 (2.1) | <.001 |
| Renal disorder | 17 890 (2.1) | 16 448 (2.1) | 1442 (1.7) | <.001 |
| Sickle cell disease | 1178 (0.1) | 1000 (0.1) | 178 (0.2) | <.001 |
| Trisomy 21 | 280 (<0.1) | 257 (<0.1) | 23 (<0.1) | .510 |